FT.com
For World TB Day, the Financial Times’ Andrew Jack interviewed various members of the TB community to get their take on a range of topics:
- Paul Stoffels, head of R&D at Johnson & Johnson, explains why drugs to cope with tuberculosis have been slow to emerge from the pipelines of the world’s pharmaceutical companies.
- Lucy Cheshire, a Kenyan campaigner who was treated for the disease 10 years ago, explains how months of antibiotics and social stigma make tuberculosis a very difficult disease to cope with.
- Paul Sommerfeld, chairman of TB Alert, a global advocacy group, discusses the spread of TB across the world.
- Al Story, the clinical lead of a UK charity, discusses how tuberculosis in the UK is rising by 5% a year, with the problem most acute among drug users and the homeless.
